Xenon Pharmaceuticals XENE Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Xenon Pharmaceuticals’s reported figures.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xenon Pharmaceuticals's invested capital?
- Xenon Pharmaceuticals (XENE) reported invested capital of $799.44M in Q1 2026.
- How has Xenon Pharmaceuticals's invested capital changed year-over-year?
- Xenon Pharmaceuticals's invested capital increased by 34.1% year-over-year, from $595.98M to $799.44M.
- What is the long-term trend for Xenon Pharmaceuticals's invested capital?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's invested capital has grown at a 24.7% compound annual growth rate (CAGR), from $129.66M to $390.54M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).